当前位置: X-MOL 学术Int. Arch. Allergy Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Implementation of the MASK-Air® App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study
International Archives of Allergy and Immunology ( IF 2.5 ) Pub Date : 2021-09-22 , DOI: 10.1159/000518032
Maria Teresa Ventura 1 , Antonio Francesco Maria Giuliano 1 , Rosalba Buquicchio 2 , Anna Bedbrook 3 , Wienczyslawa Czarlewski 4, 5 , Daniel Laune 6 , Vincenzo Patella 7 , Giorgio Walter Canonica 8 , Jean Bousquet 3, 9, 10
Affiliation  

Introduction: MASK-air® is an app whose aim is to reduce the global burden of allergic rhinitis and asthma. A transfer of innovative practices was performed to disseminate and implement MASK-air® in European regions. The aim of the study was to examine the implementation of the MASK-air® app in older adults of the Puglia TWINNING in order to investigate (i) the rate of acceptance in this population, (ii) the reasons for refusal and (iii) the evaluation of the app after its use. Methods: All consecutive geriatric patients aged between 65 and 90 years were included by the outpatient clinic of the Bari Geriatric Immunoallergology Unit. After a 1-h training session, older adults used the app for 6 months. A 6-item questionnaire was developed by our unit to evaluate the impact of the app on the management of the disease and its treatment. Results: Among the 174 recruited patients, 102 accepted to use the app (mean age, SD: 72.4 ± 4.6 years), 6 were lost to follow-up, and 63 had a low education level. The reasons given not to use the app included lack of interest (11%), lack of access to a smartphone or tablet (53%), low computer literacy (28%), and distrust (8%). At follow-up, the overall satisfaction was high (89%), the patient considered MASK-air® “advantageous” (95%), compliance to treatment was improved (81%), and the rate of loss to follow-up had decreased to 6%. Conclusion: Older adults with a low level of education can use the MASK-air® app after a short training session.
Int Arch Allergy Immunol


中文翻译:

针对老年人鼻炎和哮喘的 MASK-Air® 应用程序的实施:MASK@Puglia 试点研究

简介: MASK-air® 是一款旨在减轻全球过敏性鼻炎和哮喘负担的应用程序。进行了创新实践的转移,以在欧洲地区传播和实施 MASK-air®。该研究的目的是检查 MASK-air® 应用程序在 Puglia TWINNING 的老年人中的实施情况,以调查 (i) 该人群的接受率,(ii) 拒绝的原因和 (iii)应用程序使用后的评估。方法:所有年龄在 65 至 90 岁之间的连续老年患者均被巴里老年免疫过敏科门诊部纳入。经过 1 小时的培训课程后,老年人使用该应用程序 6 个月。我们单位开发了一份 6 项问卷,以评估该应用程序对疾病管理及其治疗的影响。结果:在招募的 174 名患者中,102 人接受使用该应用程序(平均年龄,SD:72.4 ± 4.6 岁),6 人失访,63 人文化程度低。不使用该应用程序的原因包括缺乏兴趣 (11%)、无法使用智能手机或平板电脑 (53%)、计算机素养低 (28%) 和不信任 (8%)。随访时,总体满意度高(89%),患者认为 MASK-air®“有优势”(95%),治疗依从性提高(81%),失访率下降到 6%。结论:受教育程度低的老年人可以在短期培训后使用 MASK-air® 应用程序。
Int Arch 过敏免疫
更新日期:2021-09-22
down
wechat
bug